e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Venous thromboembolic disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristic and risk factors of chronic thromboembolic pulmonary hypertension: experience in a general hospital
Y. Yang, Z. Zhai, C. Wang, B. Pang (Beijing, China)
Source:
Annual Congress 2007 - Venous thromboembolic disease
Session:
Venous thromboembolic disease
Session type:
Thematic Poster Session
Number:
3549
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Yang, Z. Zhai, C. Wang, B. Pang (Beijing, China). Characteristic and risk factors of chronic thromboembolic pulmonary hypertension: experience in a general hospital. Eur Respir J 2007; 30: Suppl. 51, 3549
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Chronic thromboembolic pulmonary hypertension and associated medical conditions
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Predictors of poor outcome in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
Source: Eur Respir J 2013; 41: 462-468
Year: 2013
Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
The changing landscape of chronic thromboembolic pulmonary hypertension management
Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017
Year: 2017
Type of anticoagulant therapy as a risk factor for the severity of chronic thromboembolic pulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Characteristics of chronic thromboembolic pulmonary hypertension in Ireland
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016
Year: 2017
A roadmap for management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019
Year: 2019
The prevalence of pulmonary hypertension and the related factors in hemodialysis patients
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history
Source: Eur Respir Rev 2009; 18: 170-173
Year: 2009
Prognostic factors in non-surgical chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept